Pre-clinical toxicology from a top preclinical Contract Research Organization in Kiev, UA.
Our company is an independent CRO operating out of the USA that provides preclinical medicine trials in top-notch, Good Laboratory Practices certified testing sites in Eastern Europe. Our testing sites are supported by the UNAMS and Ministry of Health and provide support for commercial development of new medicine discoveries as part of their main purpose. Our company was founded to offer the top-notch, low-cost services of these research sites to new bio-tech companies in the United States and EU, thereby providing them with an attractive option for promoting development programs rapidly and at much lower cost than other commercial CROs. We provide a broad range of preclinical research including medicine safety, acute and chronic toxicity, pharmacological screening, bioavailability, bio-equivalence , and extensive in vitro and in vivo screening for anticancer activity.
Our preclinical Contract Research Organization is able to price pre-clinical services far below other CROs because we have a very low overhead in the United States and perform all trials in Ukraine where personnel and facility costs are much lower. Our team in the USA is comprised of only of the organization principals who work directly with customers; we don’t have any promotion expenses aside from our site, and no head offices, administrative staff or other overhead to increase costs. We have much lower study conduct costs in Ukraine due to much lower workers rates and are happy to provide our most attractive pricing for long-term and more intricate pre-clinical trials where labor is the most significant part of the overall cost. Because we utilize the same reliable international suppliers for animal models, reagents and lab supplies as other CROs, we don’t have any cost savings on these materials and so less overall cost advantage for very short-term pre-clinical trials. However, regardless of your test protocol and duration, our goal is to give our customers the greatest possible value for their investment.